Literature DB >> 27138635

[Report on the 5th symposium of the German research network bladder carcinoma].

S Füssel1, M W Kramer2, R Stöhr3, P Olbert4, R Nawroth5, W A Schulz6.   

Abstract

Entities:  

Year:  2016        PMID： 27138635     DOI： 10.1007/s00120-016-0100-y

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  9 in total

1.  N-Acetyltransferase 2: ultra-slow acetylators enter the stage.

Authors:  S Selinski; M Blaszkewicz; S Getzmann; K Golka
Journal:  Arch Toxicol       Date:  2015-12       Impact factor: 5.153

2.  Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.

Authors:  Maria Pinkerneil; Michèle J Hoffmann; René Deenen; Karl Köhrer; Tanja Arent; Wolfgang A Schulz; Günter Niegisch
Journal:  Mol Cancer Ther       Date:  2016-01-15       Impact factor: 6.261

3.  Analysis of disease-associated protein expression using quantitative proteomics—fibulin-5 is expressed in association with hepatic fibrosis.

Authors:  Thilo Bracht; Vincent Schweinsberg; Martin Trippler; Michael Kohl; Maike Ahrens; Juliet Padden; Wael Naboulsi; Katalin Barkovits; Dominik A Megger; Martin Eisenacher; Christoph H Borchers; Jörg F Schlaak; Andreas-Claudius Hoffmann; Frank Weber; Hideo A Baba; Helmut E Meyer; Barbara Sitek
Journal:  J Proteome Res       Date:  2015-04-06       Impact factor: 4.466

4.  A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription.

Authors:  A-S Musahl; X Huang; S Rusakiewicz; E Ntini; A Marsico; G Kroemer; O Kepp; U A Ørom
Journal:  Oncogene       Date:  2015-01-12       Impact factor: 9.867

Review 5.  Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.

Authors:  Nikolas H Stoecklein; Johannes C Fischer; Dieter Niederacher; Leon W M M Terstappen
Journal:  Expert Rev Mol Diagn       Date:  2015-12-16       Impact factor: 5.225

Review 6.  [YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?].

Authors:  P S Holm; M Retz; J E Gschwend; R Nawroth
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

7.  Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion.

Authors:  Jitendra K Meena; Aurora Cerutti; Christine Beichler; Yohei Morita; Christopher Bruhn; Mukesh Kumar; Johann M Kraus; Michael R Speicher; Zhao-Qi Wang; Hans A Kestler; Fabrizio d'Adda di Fagagna; Cagatay Günes; Karl Lenhard Rudolph
Journal:  EMBO J       Date:  2015-03-27       Impact factor: 11.598

8.  Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy.

Authors:  A Sathe; F Guerth; M V Cronauer; M M Heck; M Thalgott; J E Gschwend; M Retz; R Nawroth
Journal:  Br J Cancer       Date:  2014-11-04       Impact factor: 7.640

9.  Limited Funds for Bladder Cancer Research and What Can We Do About It.

Authors:  Joost L Boormans; Ellen C Zwarthoff
Journal:  Bladder Cancer       Date:  2016-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.